Evidence map›Paper›PMID 35260787›Full record

Trial reportNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2022

Cortical dopamine reduces the impact of motivational biases governing automated behaviour.

Vanessa Scholz, Roxanne W Hook, Mojtaba Rostami Kandroodi, Johannes Algermissen, Konstantinos Ioannidis, David Christmas, Stephanie Valle, Trevor W Robbins, Jon E Grant, Samuel R Chamberlain and 1 more

Registry-linked trialOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06027723 (Effects of Acute Nicotine Administration on Motivational Mechanisms), which is not on this map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06027723 early_phase1unknown statusnot on this mapstarted 2023, after this paper: background citation

Effects of Acute Nicotine Administration on Motivational Mechanisms

TypeinterventionalSponsorUniversity of Southern CaliforniaRan2023 to 2024Enrolled40ConditionsNicotine Vaping, Nicotine DependenceArmsNicotine, Placebo
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 5 countries.

Vanessa ScholzDonders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands. vanessa.scholz@donders.ru.nl.ORCID http://orcid.org/0000-0002-7980-9659
Roxanne W HookDepartment of Psychiatry, University of Cambridge, Cambridge, UK.
Mojtaba Rostami KandroodiDonders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands.
Johannes AlgermissenDonders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands.ORCID http://orcid.org/0000-0002-1694-7069
Konstantinos IoannidisDepartment of Psychiatry, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0002-1537-5425
David ChristmasDepartment of Psychiatry, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0001-5423-0221
Stephanie ValleDepartment of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, IL, USA.
Trevor W RobbinsDepartment of Psychology, and Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0003-0642-5977
Jon E GrantDepartment of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, IL, USA.
Samuel R Chamberlain *Department of Psychiatry, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0001-7014-8121
Hanneke E M den Ouden *Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands. hanneke.denouden@donders.ru.nl.ORCID http://orcid.org/0000-0001-7039-5130
University of Cambridge · GBRadboud University Nijmegen · NLUniversity of Chicago · US

Funding

Wellcome Trust 110049
6 · The paper itself

Abstract

Motivations shape our behaviour: the promise of reward invigorates, while in the face of punishment, we hold back. Abnormalities of motivational processing are implicated in clinical disorders characterised by excessive habits and loss of top-down control, notably substance and behavioural addictions. Striatal and frontal dopamine have been hypothesised to play complementary roles in the respective generation and control of these motivational biases. However, while dopaminergic interventions have indeed been found to modulate motivational biases, these previous pharmacological studies used regionally non-selective pharmacological agents. Here, we tested the hypothesis that frontal dopamine controls the balance between Pavlovian, bias-driven automated responding and instrumentally learned action values. Specifically, we examined whether selective enhancement of cortical dopamine either (i) enables adaptive suppression of Pavlovian control when biases are maladaptive; or (ii) non-specifically modulates the degree of bias-driven automated responding. Healthy individuals (n = 35) received the catechol-o-methyltransferase (COMT) inhibitor tolcapone in a randomised, double-blind, placebo-controlled cross-over design, and completed a motivational Go NoGo task known to elicit motivational biases. In support of hypothesis (ii), tolcapone globally decreased motivational bias. Specifically, tolcapone improved performance on trials where the bias was unhelpful, but impaired performance in bias-congruent conditions. These results indicate a non-selective role for cortical dopamine in the regulation of motivational processes underpinning top-down control over automated behaviour. The findings have direct relevance to understanding neurobiological mechanisms underpinning addiction and obsessive-compulsive disorders, as well as highlighting a potential trans-diagnostic novel mechanism to address such symptoms.

Indexed as

Catechol O-MethyltransferaseDopamineBiasCatechol O-Methyltransferase InhibitorsHumansMotivationTolcaponeCatechol O-MethyltransferaseCatechol O-Methyltransferase InhibitorsDopamineTolcapone

Identifiers

PMID35260787
PMCPMC9206002
OpenAlexW4220940684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.